These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 37878893)
1. Real-Life Data on Hydroxychloroquine or Chloroquine with or Without Azithromycin in COVID-19 Patients: A Retrospective Analysis in Brazil. Souza-Silva MVR; Pereira DN; Pires MC; Vasconcelos IM; Schwarzbold AV; Vasconcelos DH; Pereira EC; Manenti ERF; Costa FR; Aguiar FC; Anschau F; Bartolazzi F; Nascimento GF; Vianna HR; Batista JDL; Machado-Rugolo J; Ruschel KB; Ferreira MAP; Oliveira LS; Menezes LSM; Ziegelmann PK; Tofani MGT; Bicalho MAC; Nogueira MCA; Guimarães-Júnior MH; Aguiar RLO; Rios DRA; Polanczyk CA; Marcolino MS Arq Bras Cardiol; 2023 Sep; 120(9):e20220935. PubMed ID: 37878893 [TBL] [Abstract][Full Text] [Related]
2. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients. Lammers AJJ; Brohet RM; Theunissen REP; Koster C; Rood R; Verhagen DWM; Brinkman K; Hassing RJ; Dofferhoff A; El Moussaoui R; Hermanides G; Ellerbroek J; Bokhizzou N; Visser H; van den Berge M; Bax H; Postma DF; Groeneveld PHP Int J Infect Dis; 2020 Dec; 101():283-289. PubMed ID: 33007454 [TBL] [Abstract][Full Text] [Related]
3. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial. Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282 [TBL] [Abstract][Full Text] [Related]
4. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Furtado RHM; Berwanger O; Fonseca HA; Corrêa TD; Ferraz LR; Lapa MG; Zampieri FG; Veiga VC; Azevedo LCP; Rosa RG; Lopes RD; Avezum A; Manoel ALO; Piza FMT; Martins PA; Lisboa TC; Pereira AJ; Olivato GB; Dantas VCS; Milan EP; Gebara OCE; Amazonas RB; Oliveira MB; Soares RVP; Moia DDF; Piano LPA; Castilho K; Momesso RGRAP; Schettino GPP; Rizzo LV; Neto AS; Machado FR; Cavalcanti AB; Lancet; 2020 Oct; 396(10256):959-967. PubMed ID: 32896292 [TBL] [Abstract][Full Text] [Related]
5. Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19 pneumonia: A retrospective study. Saib A; Amara W; Wang P; Cattan S; Dellal A; Regaieg K; Nahon S; Nallet O; Nguyen LS PLoS One; 2021; 16(6):e0252388. PubMed ID: 34106964 [TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19. Özdemir İH; Özlek B; Özen MB; Gündüz R; Çetin N; Bilge AR Int J Clin Pract; 2021 Feb; 75(2):e13896. PubMed ID: 33280207 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis. Kashour Z; Riaz M; Garbati MA; AlDosary O; Tlayjeh H; Gerberi D; Murad MH; Sohail MR; Kashour T; Tleyjeh IM J Antimicrob Chemother; 2021 Jan; 76(1):30-42. PubMed ID: 33031488 [TBL] [Abstract][Full Text] [Related]
8. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine. Sarayani A; Cicali B; Henriksen CH; Brown JD Res Social Adm Pharm; 2021 Feb; 17(2):483-486. PubMed ID: 32327397 [TBL] [Abstract][Full Text] [Related]
9. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662 [TBL] [Abstract][Full Text] [Related]
10. Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase. Saint-Gerons DM; Tabarés-Seisdedos R Eur J Clin Pharmacol; 2021 Oct; 77(10):1513-1521. PubMed ID: 33938974 [TBL] [Abstract][Full Text] [Related]
11. Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients. Carlucci PM; Ahuja T; Petrilli C; Rajagopalan H; Jones S; Rahimian J J Med Microbiol; 2020 Oct; 69(10):1228-1234. PubMed ID: 32930657 [No Abstract] [Full Text] [Related]
12. Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study. Okada JI; Yoshinaga T; Washio T; Sawada K; Sugiura S; Hisada T Clin Transl Sci; 2021 May; 14(3):1092-1100. PubMed ID: 33404133 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports. Goldman A; Bomze D; Dankner R; Hod H; Meirson T; Boursi B; Maor E Br J Clin Pharmacol; 2021 Mar; 87(3):1432-1442. PubMed ID: 32964535 [TBL] [Abstract][Full Text] [Related]
14. Effect of Hydroxychloroquine and Azithromycin on QT Interval Prolongation and Other Cardiac Arrhythmias in COVID-19 Confirmed Patients. Eftekhar SP; Kazemi S; Barary M; Javanian M; Ebrahimpour S; Ziaei N Cardiovasc Ther; 2021; 2021():6683098. PubMed ID: 33688374 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes and adverse events in patients hospitalised with COVID-19, treated with off-label hydroxychloroquine and azithromycin. Kelly M; O'Connor R; Townsend L; Coghlan M; Relihan E; Moriarty M; Carr B; Melanophy G; Doyle C; Bannan C; O'Riordan R; Merry C; Clarke S; Bergin C Br J Clin Pharmacol; 2021 Mar; 87(3):1150-1154. PubMed ID: 32687645 [TBL] [Abstract][Full Text] [Related]
16. The Efficacy of Hydroxychloroquine and Azithromycin Combination Therapy on Hospital Mortality in COVID 19 Pneumonia Patients. Özuygur Ermiş SS; Ergan B; Kaçmaz Başoğlu Ö; Ercan S; Korkmaz Ekren P; Kuruüzüm Z; Özhan MH; Sayiner AA; Savran Y; Sertöz ŞR; Taşbakan MS; Kilinç O; Sayiner A Turk J Med Sci; 2021 Aug; ():. PubMed ID: 34344140 [TBL] [Abstract][Full Text] [Related]
17. A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment. Ghazy RM; Almaghraby A; Shaaban R; Kamal A; Beshir H; Moursi A; Ramadan A; Taha SHN Sci Rep; 2020 Dec; 10(1):22139. PubMed ID: 33335141 [TBL] [Abstract][Full Text] [Related]
18. Pharmacoepidemiology, Machine Learning, and COVID-19: An Intent-to-Treat Analysis of Hydroxychloroquine, With or Without Azithromycin, and COVID-19 Outcomes Among Hospitalized US Veterans. Gerlovin H; Posner DC; Ho YL; Rentsch CT; Tate JP; King JT; Kurgansky KE; Danciu I; Costa L; Linares FA; Goethert ID; Jacobson DA; Freiberg MS; Begoli E; Muralidhar S; Ramoni RB; Tourassi G; Gaziano JM; Justice AC; Gagnon DR; Cho K Am J Epidemiol; 2021 Nov; 190(11):2405-2419. PubMed ID: 34165150 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis. Kumar J; Jain S; Meena J; Yadav A J Infect Chemother; 2021 Jun; 27(6):882-889. PubMed ID: 33678548 [TBL] [Abstract][Full Text] [Related]
20. Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Chen Z; Liu A; Cheng Y; Wang X; Xu X; Huang J; Ma Y; Gao M; Huang C BMC Infect Dis; 2021 Aug; 21(1):805. PubMed ID: 34384388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]